Emblaveo — Compare Prices at US & Canada Pharmacies
Compare real Emblaveo prices at US and Canadian pharmacies, see official FDA uses and warnings, and find generic alternatives.
What is the typical out-of-pocket cost for Emblaveo without health insurance?
The standard retail price for Emblaveo is $4,072.95 per 10 vials of 1.5-0.5 gm solution for reconstitution when purchased without insurance. However, uninsured patients may be able to lower this amount by using prescription discount programs or coupons, which are often available through pharmacy chains or online discount services. Prices can vary by pharmacy location and the specific discount program used.
What will Emblaveo cost if I have insurance coverage?
Insurance coverage for Emblaveo depends entirely on your specific plan. Some insurance policies may cover this medication while others do not. To find out whether your plan includes Emblaveo and what your out-of-pocket responsibility would be, contact your insurance company directly and ask about coverage, copayments, and coinsurance amounts. If your insurer does not cover Emblaveo or if your copay is high, you may want to compare prices using pharmacy discount programs or coupons available at major pharmacy chains. Patients with Medicare or Medicaid should also contact their respective programs to verify coverage details before filling a prescription.
Is a generic form of Emblaveo available?
Emblaveo is a brand-name medication manufactured by AbbVie. Currently, no generic equivalent has been approved by the FDA, so brand-name Emblaveo is the only formulation available in the United States.
Emblaveo prices at US pharmacies
Emblaveo — solution reconstituted, 1.5-0.5gm, qty 10
| Pharmacy | Retail price | With discount card |
|---|---|---|
| Kroger Pharmacy Lowest | $3362.96 | $3359.96 |
| Harris Teeter Pharmacy | $3362.96 | $3359.96 |
| CVS Pharmacy | $3503.47 | $3500.47 |
| Walgreens | $3529.52 | $3526.52 |
| Publix | $3551.37 | $3548.37 |
| Walmart Neighborhood Market | $3610.69 | $3607.69 |
| Walmart Pharmacy | $3610.69 | $3607.69 |
| Costco | $3630.78 | $3627.78 |
Emblaveo prices at Canadian pharmacies
No Canadian pharmacy pricing was found for Emblaveo in our latest data pull.
Canada prices are converted to USD at time of collection and shown per tablet where available. Ordering from Canadian pharmacies is legal for personal use in most cases but subject to FDA/CBSA rules — see US vs Canada, explained.
What is Emblaveo used for?
Emblaveo combines aztreonam (a monobactam antibiotic) with avibactam (a beta-lactamase inhibitor), and — used together with metronidazole — is FDA-approved for complicated intra-abdominal infections in adults who have limited or no other treatment options. It fills a specific gap in the antibiotic arsenal: aztreonam alone resists a class of resistance enzymes called metallo-beta-lactamases, but many resistant bacteria that produce those enzymes also produce a second type that would normally destroy aztreonam too — avibactam blocks that second type, restoring aztreonam's effectiveness against organisms that would otherwise defeat it on both fronts.
Because of this, Emblaveo is particularly relevant for certain hard-to-treat carbapenem-resistant Enterobacterales (CRE) infections that don't respond to more commonly used Reserve antibiotics. The FDA's approval was explicitly based on limited clinical data, reflecting how this drug reached patients through a pathway designed for serious infections with few alternatives, and the WHO AWaRe framework classifies it as a Reserve antibiotic for exactly this reason.
Emblaveo is given only by IV infusion, almost always in a hospital, and is meant to be used only when a resistant infection is confirmed or strongly suspected — not as a routine choice — both to protect patients and to help preserve its usefulness for the infections it was specifically developed to treat.
How Emblaveo works
Aztreonam attacks the cell wall
Like other beta-lactams, it blocks the enzymes gram-negative bacteria need to build their cell wall.
Avibactam disables a key bacterial defense
It inhibits a broad range of beta-lactamase enzymes, including some that would otherwise destroy aztreonam.
Reaches infections other Reserve drugs can't
Because aztreonam itself resists a different class of resistance enzymes (metallo-beta-lactamases), the combination covers resistant bacteria that defeat other antibiotics through either mechanism alone.
Available forms
solution reconstituted
Related & alternative drugs
Warnings & interactions
This is a summary of the official FDA label text, not personalized medical advice. It does not list every possible interaction or side effect. Always tell your prescriber and pharmacist about every medicine and supplement you take.
Common, usually mild
- Infusion-site pain or irritation
- Nausea, vomiting, diarrhea
Serious — seek care promptly
- Signs of an allergic reaction: hives, swelling, difficulty breathing
- Severe or watery diarrhea (possible C. diff colitis)
Contraindications
4 CONTRAINDICATIONS EMBLAVEO is contraindicated in patients with known hypersensitivity to the components of EMBLAVEO (aztreonam and avibactam) [see Warnings and Precautions ( 5.1 )] . Known hypersensitivity to the components of EMBLAVEO (aztreonam and avibactam). ( 4 )
Notable drug interactions
| Drug / substance | What can happen |
|---|---|
| Probenecid | Not recommended — inhibits transporters that clear avibactam, potentially reducing its elimination. |
Pregnancy & breastfeeding
8.1 Pregnancy Risk Summary There are no data on the effects of EMBLAVEO use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. Available data from case reports over several decades with aztreonam and over approximately a decade with avibactam have not identified a drug-associated risk of major birth defects, miscarriage or other maternal or fetal outcomes.
Frequently asked questions
How much does Emblaveo cost without insurance?
Is there a generic version of Emblaveo?
What drug class is Emblaveo in?
Page info
Prices last checked 2026-08-21. Reviewed against FDA and DailyMed official sources — see our review process. Not a substitute for professional medical advice.
Kami Kim, M.D., Infectious Diseases, Global Health